N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis

Background: Oral and enteral mucositis due to high-dose cytostatic treatment administered during autologous and allogeneic stem-cell transplantation increases mortality. Salivary secretory immunoglobulin A (sIgA) is a basic pillar of local immunity in the first line of defense. Altered salivary sial...

Full description

Bibliographic Details
Main Authors: Enikő Gebri, Zsuzsanna Kovács, Brigitta Mészáros, Ferenc Tóth, Ádám Simon, Hajnalka Jankovics, Ferenc Vonderviszt, Attila Kiss, András Guttman, Tibor Hortobágyi
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/6/1747
_version_ 1797566106447118336
author Enikő Gebri
Zsuzsanna Kovács
Brigitta Mészáros
Ferenc Tóth
Ádám Simon
Hajnalka Jankovics
Ferenc Vonderviszt
Attila Kiss
András Guttman
Tibor Hortobágyi
author_facet Enikő Gebri
Zsuzsanna Kovács
Brigitta Mészáros
Ferenc Tóth
Ádám Simon
Hajnalka Jankovics
Ferenc Vonderviszt
Attila Kiss
András Guttman
Tibor Hortobágyi
author_sort Enikő Gebri
collection DOAJ
description Background: Oral and enteral mucositis due to high-dose cytostatic treatment administered during autologous and allogeneic stem-cell transplantation increases mortality. Salivary secretory immunoglobulin A (sIgA) is a basic pillar of local immunity in the first line of defense. Altered salivary sialoglycoprotein carbohydrates are important in the pathologies in the oral cavity including inflammation, infection and neoplasia. Therefore, we assessed whether changes in the salivary and serum IgA glycosylation correlated with development and severity of oral mucositis. Methods: Using capillary electrophoresis, comparative analysis of serum and salivary IgA total N-glycans was conducted in 8 patients with autologous peripheral stem-cell transplantation (APSCT) at four different stages of transplantation (day −3/−7, 0, +7, +14) and in 10 healthy controls. Results: Fourteen out of the 31 structures identified in serum and 6 out of 38 in saliva showed significant changes upon transplantation compared with the control group. Only serum core fucosylated, sialylated bisecting biantennary glycan (FA2BG2S2) showed significant differences between any two stages of transplantation (day −3/−7 and day +14; <i>p</i> = 0.0279). Conclusion: Our results suggest that changes in the serum IgA total N-glycan profile could serve as a disease-specific biomarker in patients undergoing APSCT, while analysis of salivary IgA N-glycan reflects the effect of APSCT on local immunity.
first_indexed 2024-03-10T19:22:01Z
format Article
id doaj.art-a307021fa9254796b1a12574207a9145
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T19:22:01Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-a307021fa9254796b1a12574207a91452023-11-20T02:55:35ZengMDPI AGJournal of Clinical Medicine2077-03832020-06-0196174710.3390/jcm9061747N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral MucositisEnikő Gebri0Zsuzsanna Kovács1Brigitta Mészáros2Ferenc Tóth3Ádám Simon4Hajnalka Jankovics5Ferenc Vonderviszt6Attila Kiss7András Guttman8Tibor Hortobágyi9Department of Dentoalveolar Surgery and Dental Outpatient Care, Faculty of Dentistry, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryHorváth Csaba Laboratory of Bioseparation Sciences, Research Center for Molecular Medicine, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryHorváth Csaba Laboratory of Bioseparation Sciences, Research Center for Molecular Medicine, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryDepartment of Biomaterials and Prosthetic Dentistry, Faculty of Dentistry, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryHorváth Csaba Laboratory of Bioseparation Sciences, Research Center for Molecular Medicine, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryResearch Institute of Biomolecular and Chemical Engineering, University of Pannonia, Egyetem u 10., H-8200 Veszprém, HungaryResearch Institute of Biomolecular and Chemical Engineering, University of Pannonia, Egyetem u 10., H-8200 Veszprém, HungaryDepartment of Hematopoietic Transplantation Centre, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryHorváth Csaba Laboratory of Bioseparation Sciences, Research Center for Molecular Medicine, Doctoral School of Molecular Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, HungaryInstitute of Pathology, Faculty of Medicine, University of Szeged, Állomás utca 1., H-6725 Szeged, HungaryBackground: Oral and enteral mucositis due to high-dose cytostatic treatment administered during autologous and allogeneic stem-cell transplantation increases mortality. Salivary secretory immunoglobulin A (sIgA) is a basic pillar of local immunity in the first line of defense. Altered salivary sialoglycoprotein carbohydrates are important in the pathologies in the oral cavity including inflammation, infection and neoplasia. Therefore, we assessed whether changes in the salivary and serum IgA glycosylation correlated with development and severity of oral mucositis. Methods: Using capillary electrophoresis, comparative analysis of serum and salivary IgA total N-glycans was conducted in 8 patients with autologous peripheral stem-cell transplantation (APSCT) at four different stages of transplantation (day −3/−7, 0, +7, +14) and in 10 healthy controls. Results: Fourteen out of the 31 structures identified in serum and 6 out of 38 in saliva showed significant changes upon transplantation compared with the control group. Only serum core fucosylated, sialylated bisecting biantennary glycan (FA2BG2S2) showed significant differences between any two stages of transplantation (day −3/−7 and day +14; <i>p</i> = 0.0279). Conclusion: Our results suggest that changes in the serum IgA total N-glycan profile could serve as a disease-specific biomarker in patients undergoing APSCT, while analysis of salivary IgA N-glycan reflects the effect of APSCT on local immunity.https://www.mdpi.com/2077-0383/9/6/1747autologous peripheral stem-cell transplantation (APSCT)glycomicsglycoproteinimmunoglobulinsIgAoral immunity
spellingShingle Enikő Gebri
Zsuzsanna Kovács
Brigitta Mészáros
Ferenc Tóth
Ádám Simon
Hajnalka Jankovics
Ferenc Vonderviszt
Attila Kiss
András Guttman
Tibor Hortobágyi
N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis
Journal of Clinical Medicine
autologous peripheral stem-cell transplantation (APSCT)
glycomics
glycoprotein
immunoglobulins
IgA
oral immunity
title N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis
title_full N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis
title_fullStr N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis
title_full_unstemmed N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis
title_short N-Glycosylation Alteration of Serum and Salivary Immunoglobulin A Is a Possible Biomarker in Oral Mucositis
title_sort n glycosylation alteration of serum and salivary immunoglobulin a is a possible biomarker in oral mucositis
topic autologous peripheral stem-cell transplantation (APSCT)
glycomics
glycoprotein
immunoglobulins
IgA
oral immunity
url https://www.mdpi.com/2077-0383/9/6/1747
work_keys_str_mv AT enikogebri nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT zsuzsannakovacs nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT brigittameszaros nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT ferenctoth nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT adamsimon nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT hajnalkajankovics nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT ferencvonderviszt nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT attilakiss nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT andrasguttman nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis
AT tiborhortobagyi nglycosylationalterationofserumandsalivaryimmunoglobulinaisapossiblebiomarkerinoralmucositis